Detalhe da pesquisa
1.
The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset.
Curr Issues Mol Biol
; 44(11): 5498-5515, 2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36354684
2.
Role of miRNAs in Human T Cell Leukemia Virus Type 1 Induced T Cell Leukemia: A Literature Review and Bioinformatics Approach.
Int J Mol Sci
; 23(10)2022 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628297
3.
Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.
Int J Mol Sci
; 23(15)2022 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35897788
4.
Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution.
Int J Mol Sci
; 23(7)2022 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35409190
5.
Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.
Cancer Diagn Progn
; 4(1): 9-24, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38173664
6.
Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia Patients.
Anticancer Res
; 44(6): 2747-2753, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38821591
7.
Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Chain Reaction for Acute Leukemia Gene Expression Studies.
Genes (Basel)
; 15(2)2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397141
8.
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia.
Biomedicines
; 11(4)2023 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37189716
9.
PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia.
Cancers (Basel)
; 15(23)2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067214
10.
Leukemic Stem Cell: A Mini-Review on Clinical Perspectives.
Front Oncol
; 12: 931050, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35814466
11.
Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives.
Pharmaceutics
; 14(9)2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36145532
12.
Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.
Pharmaceutics
; 13(10)2021 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34683897
13.
Kinase inhibition in multiple myeloma: current scenario and clinical perspectives
BARRETO, Igor Valentim et al. Kinase inhibition in multiple myeloma: current scenario and clinical perspectives. Pharmaceutics, v. 14, n. 9, p. 1-16, Aug. 2022. DOI: 10.3390/pharmaceutics14091784. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506264/pdf/pharmaceutics-14-01784.pdf.
Artigo
em Inglês
| Instituto Evandro Chagas (DSpace) | ID: ied-4669